128 related articles for article (PubMed ID: 2560792)
21. A comparative study of 188Re(V)-meso-DMSA and 188Re(V)-rac-DMSA: preparation and in vivo evaluation in nude mice xenografted with a neuroendocrine tumor.
Park JY; Lee TS; Choi TH; Cheon GJ; Choi CW; Awh OD
Nucl Med Biol; 2007 Nov; 34(8):1029-36. PubMed ID: 17998108
[TBL] [Abstract][Full Text] [Related]
22. 99Tcm-diastereomeric dimercaptosuccinic acid complexes: comparison of their biodistribution.
Awh OD; Kim JR; Shim SC
Nucl Med Commun; 1989 Jun; 10(6):449-54. PubMed ID: 2549480
[TBL] [Abstract][Full Text] [Related]
23. Acute and longer term effects of meso-2,3 dimercaptosuccinic acid (DMSA) on the behavior of lead-exposed and control mice.
Stewart PW; Blaine C; Cohen M; Burright RG; Donovick PJ
Physiol Behav; 1996; 59(4-5):849-55. PubMed ID: 8778876
[TBL] [Abstract][Full Text] [Related]
24. DL- and meso-dimercaptosuccinic acid: in vitro and in vivo studies with sodium arsenite.
Aposhian HV; Hsu CA; Hoover TD
Toxicol Appl Pharmacol; 1983 Jun; 69(2):206-13. PubMed ID: 6306868
[TBL] [Abstract][Full Text] [Related]
25. Preparation of radioactive lead complexes utilizing Chelex methodology.
Lever SZ; Stricklin DL
Nucl Med Biol; 1996 Nov; 23(8):1013-7. PubMed ID: 9004291
[TBL] [Abstract][Full Text] [Related]
26. Determination and metabolism of dithiol chelating agents. VI. Isolation and identification of the mixed disulfides of meso-2,3-dimercaptosuccinic acid with L-cysteine in human urine.
Maiorino RM; Bruce DC; Aposhian HV
Toxicol Appl Pharmacol; 1989 Feb; 97(2):338-49. PubMed ID: 2538007
[TBL] [Abstract][Full Text] [Related]
27. Beneficial role of monoesters of meso-2,3-dimercaptosuccinic acid in the mobilization of lead and recovery of tissue oxidative injury in rats.
Saxena G; Pathak U; Flora SJ
Toxicology; 2005 Oct; 214(1-2):39-56. PubMed ID: 16019123
[TBL] [Abstract][Full Text] [Related]
28. Mobilization of lead over the course of DMSA chelation therapy and long-term efficacy.
Cory-Slechta DA
J Pharmacol Exp Ther; 1988 Jul; 246(1):84-91. PubMed ID: 2839672
[TBL] [Abstract][Full Text] [Related]
29. Determination and metabolism of dithiol chelating agents. XV. The meso-2,3-dimercaptosuccinic acid-cysteine (1:2) mixed disulfide, a major urinary metabolite of DMSA in the human, increases the urinary excretion of lead in the rat.
Maiorino RM; Aposhian MM; Xu ZF; Li Y; Polt RL; Aposhian HV
J Pharmacol Exp Ther; 1993 Dec; 267(3):1221-6. PubMed ID: 8263783
[TBL] [Abstract][Full Text] [Related]
30. Effect of chelation with meso-dimercaptosuccinic acid (DMSA) before and after the appearance of lead-induced neurotoxicity in the rat.
Gong Z; Evans HL
Toxicol Appl Pharmacol; 1997 Jun; 144(2):205-14. PubMed ID: 9194404
[TBL] [Abstract][Full Text] [Related]
31. Dimercaptosuccinic acid (succimer; DMSA) in inorganic lead poisoning.
Bradberry S; Vale A
Clin Toxicol (Phila); 2009 Aug; 47(7):617-31. PubMed ID: 19663612
[TBL] [Abstract][Full Text] [Related]
32. On the interaction of vanadium species with meso-2,3-dimercaptosuccinic acid.
Williams PA; Baran EJ
Biol Trace Elem Res; 2006 Feb; 109(2):189-94. PubMed ID: 16444008
[TBL] [Abstract][Full Text] [Related]
33. Intramuscular administration of iron during long-term chelation therapy with 2,3-dimercaptosuccinic acid in a man with severe lead poisoning.
Haust HL; Inwood M; Spence JD; Poon HC; Peter F
Clin Biochem; 1989 Jun; 22(3):189-96. PubMed ID: 2544323
[TBL] [Abstract][Full Text] [Related]
34. A comparison of sodium calcium edetate (edetate calcium disodium) and succimer (DMSA) in the treatment of inorganic lead poisoning.
Bradberry S; Vale A
Clin Toxicol (Phila); 2009 Nov; 47(9):841-58. PubMed ID: 19852620
[TBL] [Abstract][Full Text] [Related]
35. 2,3-Dimercaptopropane-1-sulfonic acid and meso-2,3-dimercaptosuccinic acid increase mercury- and cadmium-induced inhibition of delta-aminolevulinate dehydratase.
Nogueira CW; Soares FA; Nascimento PC; Muller D; Rocha JB
Toxicology; 2003 Mar; 184(2-3):85-95. PubMed ID: 12499112
[TBL] [Abstract][Full Text] [Related]
36. Structural characterization of Cd²⁺ complexes in solution with DMSA and DMPS.
Zeini Jahromi E; Gailer J; Pickering IJ; George GN
J Inorg Biochem; 2014 Jul; 136():99-106. PubMed ID: 24367995
[TBL] [Abstract][Full Text] [Related]
37. Effect of meso-2,3-dimercaptosuccinic acid on urinary lead excretion in exposed men.
Torres-Alanís O; Garza-Ocañas L; Piñeyro-López A
Hum Exp Toxicol; 2002 Nov; 21(11):573-7. PubMed ID: 12507251
[TBL] [Abstract][Full Text] [Related]
38. Synthesis, structure, and stability of the zinc complex of the dimethyl ester of meso-2,3-dimercaptosuccinic acid.
Rivera M; Fernando Q
Chem Res Toxicol; 1992; 5(1):142-7. PubMed ID: 1316187
[TBL] [Abstract][Full Text] [Related]
39. Effect of L-arginine, dimercaptosuccinic acid (DMSA) and the association of L-arginine and DMSA on tissue lead mobilization and blood pressure level in plumbism.
Malvezzi CK; Moreira EG; Vassilieff I; Vassilieff VS; Cordellini S
Braz J Med Biol Res; 2001 Oct; 34(10):1341-6. PubMed ID: 11593311
[TBL] [Abstract][Full Text] [Related]
40. Oral dimercaptosuccinic acid and ongoing exposure to lead: effects on heme synthesis and lead distribution in a rat model.
Pappas JB; Nuttall KL; Ahlquist JT; Allen EM; Banner W
Toxicol Appl Pharmacol; 1995 Jul; 133(1):121-9. PubMed ID: 7597702
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
